9 results
·
23ms
·
Sources: EU EUDAMED, US FDA
QualityFlow O2 Series (QualityFLOW O2); QualityFlow O2 Series (QualityFLOW O2 MTV)
FDA 510(k)
FDA Class 2
·Anesthesiology
ATLAS CUP METAL BACK III P D.52
FDA UDI
FOURNITURES HOSPITALIERES INDUSTRIE·03661489413667·
IPACS ORTHO
FDA 510(k)
FDA Class 2
·Radiology
VIDEO BRONCHOSCOPE SYSTEM
FDA 510(k)
FDA Class 2
·Ear, Nose, Throat
BD¿ NEEDLE 30X1/2 RB
FDA Adverse Event
Malfunction
·BECTON DICKINSON AND COMPANY·Product code FMI·December 4, 2019
KNEE IMPLANT
FDA Adverse Event
Injury
·SMITH & NEPHEW, INC.·Product code JWH·November 10, 2014
INSTATRAK 3500
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS (SLC)·Product code LLZ·August 17, 2011
8CM ANGLE ATTACHMENT
FDA Adverse Event
Malfunction
·DEPUY SYNTHES POWER TOOLS·Product code HBC·July 22, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014